161 related articles for article (PubMed ID: 33393492)
1. Doubling up on function: dual-specificity tyrosine-regulated kinase 1A (DYRK1A) in B cell acute lymphoblastic leukemia.
Kim JH; Li L; Resar LM
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393492
[TBL] [Abstract][Full Text] [Related]
2. DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.
Bhansali RS; Rammohan M; Lee P; Laurent AP; Wen Q; Suraneni P; Yip BH; Tsai YC; Jenni S; Bornhauser B; Siret A; Fruit C; Pacheco-Benichou A; Harris E; Besson T; Thompson BJ; Goo YA; Hijiya N; Vilenchik M; Izraeli S; Bourquin JP; Malinge S; Crispino JD
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393494
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
4. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.
Lee P; Bhansali R; Izraeli S; Hijiya N; Crispino JD
Leukemia; 2016 Sep; 30(9):1816-23. PubMed ID: 27285583
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
6. DYRK1A in Down syndrome: an oncogene or tumor suppressor?
Birger Y; Izraeli S
J Clin Invest; 2012 Mar; 122(3):807-10. PubMed ID: 22354166
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIδ signaling pathway in myocardial infarction-induced heart failure of rats.
He J; Yao J; Sheng H; Zhu J
J Card Fail; 2015 Sep; 21(9):751-60. PubMed ID: 26067684
[TBL] [Abstract][Full Text] [Related]
8. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
[TBL] [Abstract][Full Text] [Related]
9. Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Jarhad DB; Mashelkar KK; Kim HR; Noh M; Jeong LS
J Med Chem; 2018 Nov; 61(22):9791-9810. PubMed ID: 29985601
[TBL] [Abstract][Full Text] [Related]
10. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.
Adayev T; Chen-Hwang MC; Murakami N; Lee E; Bolton DC; Hwang YW
Biochemistry; 2007 Jun; 46(25):7614-24. PubMed ID: 17536841
[TBL] [Abstract][Full Text] [Related]
11. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
[TBL] [Abstract][Full Text] [Related]
12. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.
Malinge S; Bliss-Moreau M; Kirsammer G; Diebold L; Chlon T; Gurbuxani S; Crispino JD
J Clin Invest; 2012 Mar; 122(3):948-62. PubMed ID: 22354171
[TBL] [Abstract][Full Text] [Related]
13. The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target.
Rammohan M; Harris E; Bhansali RS; Zhao E; Li LS; Crispino JD
Oncogene; 2022 Apr; 41(14):2003-2011. PubMed ID: 35220406
[TBL] [Abstract][Full Text] [Related]
14. DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis.
Dierssen M; de Lagrán MM
ScientificWorldJournal; 2006 Jun; 6():1911-22. PubMed ID: 17205196
[TBL] [Abstract][Full Text] [Related]
15. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
[TBL] [Abstract][Full Text] [Related]
16. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
[TBL] [Abstract][Full Text] [Related]
17. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.
Tlili A; Noll C; Middendorp S; Duchon A; Jouan M; Benabou E; Hérault Y; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2013 Nov; 110(3):371-7. PubMed ID: 23920041
[TBL] [Abstract][Full Text] [Related]
18. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
19. DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.
Becker W; Soppa U; Tejedor FJ
CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):26-33. PubMed ID: 24152332
[TBL] [Abstract][Full Text] [Related]
20. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
